In vitro, EMT is abolished when NTSR1-overexpressing HCC cells are treated with the NTSR1 antagonist SR48692 or specific inhibitors of the Wnt/β-Catenin pathway as TSW119 or Dick kopf-1. The gene discussed is NTSR1; the disease is hepatocellular carcinoma.